← Back to all trials
Not Yet Recruiting
NCT07648420
Using Apollo Neuro in Autistic Children With Self-Injurious Behavior
Conditions: Self-Injurious Behavior, Autism Spectrum Disorder
Sex: All
Ages: 6 Years – 179 Months
Healthy volunteers: No
Phase: NA
Enrollment: 18
Sponsor: Virginia Commonwealth University
Location: Virginia Commonwealth Uniersity Richmond Virginia
Summary
This study will evaluate the feasibility and acceptability of the Apollo Neuro, a wearable vibrotactile sensory device, in autistic children who engage in self-injurious behavior (SIB).
Participants will wear the device for at least 3 hours per day over a 30-35 day period with caregiver support. Outcomes will include adherence to device use, caregiver-reported feasibility and acceptability, and descriptive characterization of caregiver-reported self- injurious and repetitive behaviors during the study period. This preliminary, single-group study is not designed to evaluate efficacy and will inform the design of future controlled trials.
Eligibility Criteria
Inclusion Criteria for child:
* Diagnosis of autism spectrum disorder (ASD), as reported by caregiver
* Presence of self-injurious behavior, as reported by caregiver
* Demonstrates sensory over and/or under- responsivity
* Aged 6 years to 14 years, 11 months (179 months) at the time of enrollment
* Has a caregiver willing and able to provide consent and participate in study procedures
Exclusion Criteria for child:
* Has medical condition that may increase risk with use of a wearable nibrotactile device, including:
* implanted medical or neurological devices (e.g., pacemaker)
* significant cardiac conditions or arrhythmias
* history of syncope (fainting)
* Known seizure disorder without physician clearance
* Regular use of nibrotactile or autonomic- modulating wearable devices within the past 90 days
* Any condition that, in the judgment of the investigator, would interfere with safe participation or interpretation of study procedures
Inclusion Criteria for Caregiver:
* Parent or legal guardian of the enrolled child participant
* Able to provide informed consent in English
* Able and willing to support device use according to study protocol and complete study-related data collection
* Has access to a smartphone or compatible device capable of operating the Apollo Neuro application for the duration of study period
Exclusion Criteria for Caregiver:
• Unable to provide informed consent in English
Source: ClinicalTrials.gov (NCT07648420). StuddyBuddy aggregates publicly available trial information.